河南建业文化旅游产业发展有限公司

内蒙古宏远达知识产权服务有限公司

内蒙古宏远达知识产权服务有限公司是一家民营性质的企业，员工人数在50人以下。该公司专注于专业服务领域，包括咨询、人力资源管理和财务会计等业务。

成都睿志辰科技有限公司

成都睿志辰科技有限公司是一家专注于卫星微波信号处理设备研发的科技公司。公司依托完全自主的知识产权，为客户提供优质可靠的产品与服务。

济南欣华工艺品设计有限公司

济南欣华工艺品设计公司诚聘英才

好印宝

珠海好印宝打印耗材有限公司是一家拥有26年复印机兼容耗材、配件研发、生产、销售经验的综合型企业。目前，“好印宝”、“HYB TONER”、“Zeus toner”、“立肯”等自主品牌已销往105个国家，成为1000多家复印影像耗材进口商的首选，是全球复印机耗材的国际知名品牌。公司研发实力雄厚，培训系统完善，产品竞争力强，是各方人才施展才华的平台。公司每年投入大量资金用于品牌宣传、品牌建设、代理商支持、国际展会、国外市场调研、B2B平台及SNS多平台推广，拥有充足的客户资源供销售人员进行业务开发。公司重视专利，已自主研发并注册专利670多项。集团公司产销一体化，处于复印机影像耗材研发的前沿，并获得多项国际质量认证。

基石药业（苏州）有限公司

CStone Pharmaceuticals is an innovative, research-driven biopharmaceutical enterprise dedicated to pioneering the development of cutting-edge therapeutic medications. Situated in both Shanghai and Suzhou, the company boasts a leadership team comprised of experienced executives from leading multinational pharmaceutical corporations. In July 2016, CStone disclosed the successful conclusion of its Series A funding round, securing a total investment of $150 million (approximately 975 million RMB). This round was co-invested by three prominent industry investors: Oriza Seed Venture Capital (Oriza Seed), Boyu Capital, and WuXi Healthcare Ventures (WXHV).

With an unwavering commitment to addressing the critical healthcare needs of Chinese patients, CStone's extensive pipeline encompasses five therapeutic areas: oncology, cardiovascular diseases, rheumatoid arthritis, hematology, and autoimmune disorders. The company's strategic focus on immuno-oncology serves as its cornerstone, aiming to propel Chinese research onto the global stage through its world-class research and development capabilities, an innovative drug portfolio, and an open innovation approach.

CStone Pharmaceuticals is a pioneering, research-focused biopharmaceutical company headquartered in Shanghai and Suzhou, China. Its executive team comprises seasoned professionals from top-tier multinational pharmaceutical firms. In July 2016, the company successfully concluded its Series A funding round, attracting a total investment of $150 million (equivalent to approximately 975 million RMB). This round was jointly supported by three distinguished industry investors: Oriza Seed Venture Capital (Oriza Seed), Boyu Capital, and WuXi Healthcare Ventures (WXHV).

Driven by a mission to meet the pressing medical needs of Chinese patients, CStone's comprehensive product pipeline spans across five therapeutic sectors: oncology, cardiovascular diseases, rheumatoid arthritis, hematology, and autoimmune diseases. With immuno-oncology at the heart of its strategic focus, the company aspires to position Chinese research on the global stage, leveraging its world-class research and development expertise, innovative drug portfolio, and an open innovation philosophy.